[Prognostic factors in multiple myeloma].
Boccadoro
M
M
Bianchi
A
A
Dianzani
U
U
Frieri
R
R
Gallone
G
G
Massaia
M
M
Omede
P
P
Palumbo
A
A
Pileri
A
A
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002455:Cell Division; D004351:Drug Resistance; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000209:etiology; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D009194:Myeloma Proteins / Q000032:analysis; D009363:Neoplasm Proteins / Q000097:blood; D014411:Neoplastic Stem Cells / Q000473:pathology; D009857:Oncogenes; D011379:Prognosis; D013937:Thymidine Kinase / Q000097:blood; D001613:beta 2-Microglobulin / Q000032:analysis
D000970:Antineoplastic Agents; D009194:Myeloma Proteins; D009363:Neoplasm Proteins; D001613:beta 2-Microglobulin; D013937:Thymidine Kinase
Fattori prognostici nel mieloma multiplo.